Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Bio-Techne (TECH) over the last 12 years, with Q4 2025 value amounting to $23.1 million.

  • Bio-Techne's Other Non-Current Liabilities rose 10356.36% to $23.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $23.1 million, marking a year-over-year increase of 10356.36%. This contributed to the annual value of $27.1 million for FY2025, which is 10583.72% up from last year.
  • Latest data reveals that Bio-Techne reported Other Non-Current Liabilities of $23.1 million as of Q4 2025, which was up 10356.36% from $23.8 million recorded in Q3 2025.
  • Over the past 5 years, Bio-Techne's Other Non-Current Liabilities peaked at $27.1 million during Q2 2025, and registered a low of $9.4 million during Q3 2023.
  • Over the past 5 years, Bio-Techne's median Other Non-Current Liabilities value was $13.0 million (recorded in 2022), while the average stood at $16.1 million.
  • In the last 5 years, Bio-Techne's Other Non-Current Liabilities tumbled by 5446.19% in 2021 and then skyrocketed by 11065.57% in 2024.
  • Over the past 5 years, Bio-Techne's Other Non-Current Liabilities (Quarter) stood at $11.7 million in 2021, then dropped by 3.5% to $11.3 million in 2022, then skyrocketed by 53.15% to $17.4 million in 2023, then plummeted by 34.7% to $11.3 million in 2024, then surged by 103.56% to $23.1 million in 2025.
  • Its Other Non-Current Liabilities stands at $23.1 million for Q4 2025, versus $23.8 million for Q3 2025 and $27.1 million for Q2 2025.